HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Kicking The CBD Can? UK Gov Accepts 0.05mg THC Limit, But Legalization Still Long Way Away

Executive Summary

The UK Home Office has accepted a suggested 0.05 mg per dose limit for controlled psychoactive substance tetrahydrocannabinol in consumer CBD products, including food supplements. However, remaining questions such as what constitutes a single dose of CBD, when UK manufacturers will be allowed to process raw cannabis, and what testing methods are needed to detect THC levels indicate that the road to compliance is still “long and winding,” argues Canna Consultants.

You may also be interested in...

UK Government Narcotics Advisors Recommend 0.05mg THC Limit For CBD Products

An advisory body to the UK government recommends a single-dose limit of 50 micrograms tetrahydrocannabinol (THC) for cannabidiol food products sold in the country. An analysis by Canna Consultants suggests this might translate in practice to today's widely assumed, although technically false, 0.2mg per retail unit limit. 

UK CBD Industry Could Be Shackled By Strict Limits For Controlled Cannabinoids

The UK government is weighing new rules on permitted levels of controlled substances, such as THC, in consumer CBD products in a departure from its light touch regulatory approach to the burgeoning market up until now.

Get To Know: ‘Medicine Cabinet Staples’ Manufacturer Kobayashi Healthcare Europe

Manufacturing best-selling items like Kool 'n' Soothe cooling sheet, Cura-Heat heat pack and Hothands hand warmer brands in its own facilities means Kobayashi Healthcare Europe can offer “great quality products without breaking the bank,” explains marketing and regulatory manager Richard Noal.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts